EMED on OTC
Electromedical Technologies, Inc
American surgical and medical instruments and apparatus company1
In its 2024 annual report the company says: “Electromedical Technologies is a bioelectronics manufacturing and marketing company. We offer U.S. Food and Drug Administration (FDA) cleared medical devices for pain management.”3 It is headquartered in Scottsdale, Arizona.1 Its shares trade on OTC under the symbol EMED.1
Price unavailable
Last updated Oct 20, 2026.
Overview
Compare with SeaStar Medical Holding Corp, PetVivo Holdings, Inc. or EBR Systems (United States), or pick any stock.
- TickerEMED on OTC1
- IndustrySurgical & Medical Instruments & Apparatus1
- HeadquartersScottsdale, Arizona1
- Incorporated inDE2
- Business address16561 N 92Nd Street, Suite 101, Scottsdale, Az 852602
- Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company2
See how the biggest companies compare on our leaderboards
The Company was formed in Nevada in August 30, 2002 as IntelSource Group, Inc. and began operations in 2003. In 2007, IntelSource Group, Inc. merged with ElectroMedical Technologies, LLC. The Company began acting as Electro Medical Technologies, LLC, an Arizona limited liability company on November 9, 2010, after the merger with ElectroMedical Technologies, LLC, a Nevada Company. The Company converted to a corporation in the State of Delaware on August 23, 2017.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue7¢$303.3K
- Research and development5¢$231.4K
- Selling, general and admin69¢$3.1M
- Interest20¢$893.2K
Out of $1.3M in revenue.4 The company lost money this year.
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenue | $829.7K5 | $738.0K6 | $907.4K7 | $1.1M4 | $1.3M4 | |
| Cost of revenue | $238.5K5 | $194.4K6 | $199.2K7 | $261.2K4 | $303.3K4 | |
| Gross profit | $591.2K5 | $543.6K6 | $708.1K7 | $888.6K4 | $1.0M4 | |
| Research and development | $82.8K5 | $31.6K6 | $215.3K7 | $92.3K4 | $231.4K4 | |
| Selling, general and admin | $2.3M5 | $3.7M6 | $4.5M7 | $2.5M4 | $3.1M4 | |
| Operating income | -$1.7M5 | -$3.2M6 | -$3.8M7 | -$1.6M4 | -$2.1M4 | |
| Interest | $54.8K5 | $769.6K6 | $3.3M7 | $791.1K4 | $893.2K4 | |
| Net income | -$1.7M5 | -$3.9M6 | -$8.5M7 | -$3.5M4 | -$2.6M4 | |
| Earnings per share | -$0.206 | -$0.247 | -$0.034 | $0.004 | ||
| Earnings per share (diluted) | -$0.206 | -$0.247 | -$0.034 | $0.004 | ||
| Shares (weighted, basic) | 51.0M shares7 | 133.6M shares4 | 377.2M shares4 | |||
| Shares (weighted, diluted) | 51.0M shares7 | 133.6M shares4 | 377.2M shares4 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Cash | $05 | $05 | $264.9K6 | $383.2K7 | $368.4K4 | $87.7K4 |
| Receivables | $35.1K7 | $9.4K4 | $4.4K4 | |||
| Inventory | $218.5K7 | $62.1K4 | $68.5K4 | |||
| Current assets | $106.2K5 | $647.2K6 | $674.8K7 | $647.8K4 | $449.2K4 | |
| Property, plant and equipment | $727.3K7 | $705.5K4 | $149.7K4 | |||
| Total assets | $902.9K5 | $1.4M6 | $1.4M7 | $1.4M4 | $748.4K4 | |
| Accounts payable | $214.8K7 | $266.7K4 | $239.5K4 | |||
| Current liabilities | $2.3M5 | $2.0M6 | $1.4M7 | $2.9M4 | $3.4M4 | |
| Long-term debt | $732.3K5 | $702.8K6 | $671.5K7 | $150.0K4 | ||
| Total liabilities | $3.1M5 | $2.7M6 | $2.1M7 | $3.6M4 | $3.6M4 | |
| Retained earnings | -$21.9M7 | -$24.8M4 | -$27.5M4 | |||
| Shareholders’ equity | -$2.1M5 | -$2.2M6 | -$1.3M7 | -$722.5K4 | -$2.2M4 | -$2.9M4 |
| Shares outstanding | 17.9M shares5 | 27.2M shares6 | 87.7M shares6 | 189.8M shares4 | 463.3M shares4 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Cash from operations | -$280.8K5 | -$1.3M6 | -$1.2M7 | -$773.3K4 | -$1.4M4 | |
| Depreciation and amortization | $21.9K7 | $21.9K4 | $4.6K4 | |||
| Stock-based compensation | $2.6M7 | $509.6K4 | $715.0K4 | |||
| Capital spending | $149.7K4 | |||||
| Free cash flow | -$1.6M | |||||
| Cash from investing | $1.7M4 | |||||
| Cash from financing | $1.3M7 | $758.6K4 | -$608.2K4 |
Compare Electromedical Technologies, Inc with another company
What it owns
What Electromedical Technologies, Inc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $174.7K4 Dec 31, 2023 | $900.0K4 Dec 31, 2022 | −80.6% |
| Accumulated depreciation | $25.0K4 Dec 31, 2023 | $194.5K4 Dec 31, 2022 | −87.2% |
| Property and equipment, net | $149.7K4 Dec 31, 2023 | $705.5K4 Dec 31, 2022 | −78.8% |
| Operating-lease assets (leased space) | $149.5K4 Dec 31, 2023 |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $87.7K4 Dec 31, 2023 | $368.4K4 Dec 31, 2022 | −76.2% |
Inventory
Leadership
Who has led Electromedical Technologies, Inc, and when. Pick a name to see everywhere that person has worked.
- Chief executive officerMatthew Wolfson Dec 10, 2020 to Feb 19, 202110
- Chief financial officerMatthew Wolfson Dec 10, 2020 to Feb 19, 202110
Board members and other officers (3)
- Board memberRobert Leslie Hymers Iii. Jan 5, 2023 to Feb 10, 202311
- Board memberLee Benson Oct 11, 2022 to Nov 2, 202212
- Board memberMatthew Wolfson Dec 10, 2020 to Feb 19, 202110
Timeline
- Aug 9, 20248-K Bylaws or fiscal year changed13
- Jul 24, 20248-K Bylaws or fiscal year changed14
- May 21, 20248-K Change of auditor15
- Apr 2, 20248-K Other events16
- Jul 5, 20238-K Executive or director change17
- Apr 20, 20238-K Regulation FD disclosure18
- Mar 21, 20238-K Entered a material agreement; Completed an acquisition or sale19
- Feb 1, 20238-K Change to shareholders' rights; Change in control; Executive or director change20
- Dec 23, 20228-K Executive or director change21
- Dec 20, 20228-K Executive or director change22
- Sep 23, 20228-K Unregistered sale of shares; Change in control; Bylaws or fiscal year changed23
- Jul 18, 20228-K Entered a material agreement; Unregistered sale of shares24
- Dec 10, 2020New chief executive Matthew Wolfson becomes CEO10
Filings
53 filings to the SEC since October 2021: 4 annual reports, 11 quarterly reports, 15 major events, 4 insider forms, 19 other. The latest 20:
- Jul 14, 202515-12G EDGAR
- Mar 31, 2025NT 10-K EDGAR
- Nov 19, 202410-Q EDGAR
- Nov 14, 2024NT 10-Q EDGAR
- Oct 18, 2024UPLOAD EDGAR
- Oct 16, 202410-K/A EDGAR
- Oct 1, 2024UPLOAD EDGAR
- Aug 14, 202410-Q EDGAR
- Aug 9, 20248-K/A EDGAR
- Jul 24, 20248-K EDGAR
- Jun 14, 202410-Q EDGAR
- May 21, 20248-K EDGAR
- May 15, 2024NT 10-Q EDGAR
- May 1, 202410-K EDGAR
- Apr 3, 2024NT 10-K EDGAR
- Apr 2, 20248-K EDGAR
- Nov 20, 202310-Q EDGAR
- Nov 15, 2023NT 10-Q EDGAR
- Aug 21, 202310-Q EDGAR
- Aug 14, 2023NT 10-Q EDGAR
The 53 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How Electromedical Technologies, Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARElectromedical Technologies, Inc1
- CIK0001715819
- Employer ID (EIN)82-26198151
- Filer statusNon-accelerated filer<br>smaller reporting company<br>emerging growth company1
- Incorporated inDelaware1
- Fiscal year endsDecember 311
- Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address16561 N 92Nd Street, Suite 101, Scottsdale, AZ 852601
- Phone888-880-78881
- Shares outstanding855,039,093 as of Nov 19, 20249
- Public float$1.3M as of Dec 31, 202325
- On EDGAR sinceSep 20, 20171
- Filings136 in all: 4 (28), 8-K (16), 10-Q (14), CORRESP (12), UPLOAD (12), S-1/A (7), 10-K (4), 3 (4)1
All 28 form types
NT 10-Q (4), 1-A/A (3), 1-K (3), 10-Q/A (3), EFFECT (3), S-1 (3), 1-SA (2), 1-U (2), 253G2 (2), NT 10-K (2), QUALIF (2), S-8 (2), 1-A (1), 10-K/A (1), 15-12G (1), 8-A12G (1), 8-K/A (1), D (1), DEL AM (1), SC 13G (1)
- Latest filingsAnnual report (10-K) May 1, 2024
Quarterly report (10-Q) Nov 19, 2024
Latest 8-K (8-K) Jul 24, 2024
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARLee Benson, Board member
- 13SEC EDGARBylaws or fiscal year changed
- 14SEC EDGARBylaws or fiscal year changed
- 15SEC EDGARChange of auditor
- 16SEC EDGAROther events
- 17SEC EDGARExecutive or director change
- 18SEC EDGARRegulation FD disclosure
- 19
- 20
- 21SEC EDGARExecutive or director change
- 22SEC EDGARExecutive or director change
- 23
- 24
- 25